COVID-19 convalescent plasma composition and immunological effects in severe patients

Convalescent plasma (CP) has emerged as a treatment for COVID-19. However, the composition and mechanism of action are not fully known. Therefore, we undertook a two-phase controlled study in which, first the immunological and metabolomic status of recovered and severe patients were evaluated. Secon...

Descripción completa

Detalles Bibliográficos
Autores principales: Acosta-Ampudia, Yeny, Monsalve, Diana M., Rojas, Manuel, Rodríguez, Yhojan, Gallo, Juan Esteban, Salazar-Uribe, Juan Carlos, Santander, María José, Cala, Mónica P., Zapata, Wildeman, Zapata, María Isabel, Manrique, Rubén, Pardo-Oviedo, Juan Mauricio, Camacho, Bernardo, Ramírez-Santana, Carolina, Anaya, Juan-Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826092/
https://www.ncbi.nlm.nih.gov/pubmed/33524876
http://dx.doi.org/10.1016/j.jaut.2021.102598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826092/
https://www.ncbi.nlm.nih.gov/pubmed/33524876
http://dx.doi.org/10.1016/j.jaut.2021.102598

Ejemplares similares